Blog
Navigating the spatial biology landscape can feel like standing in front of a massive soundboard, trying to balance dozens of sliders at once. Every platform promises single-cell or near single-cell...
In genomic research, mapping structural chromatin accessibility (scATAC-Seq) or sequencing cellular transcripts (scRNA-Seq) from separate cell aliquots provides an informative, yet fractured, perspective....
When designing a single-cell transcriptomics study, selecting the appropriate assay chemistry determines how you collect samples, manage budgets, and structure your data....
Choosing the right single-cell technology is one of the most critical decisions in modern genomic experimental design. Selecting an mismatched platform doesn’t just inflate sequencing costs—it can actively bias your...
Proteomics has never offered more ways to measure the proteome, and that abundance of choice is exactly what makes method selection difficult. Mass spectrometry, targeted assays, and affinity-based platforms each...
Multiomics research has fundamentally changed what it means to outsource NGS. It is no longer sufficient to find a vendor that can only sequence a library. Modern programs integrating RNA-seq,...
The road from protein biomarker discovery to clinical utility is rarely straight. Researchers routinely identify candidate proteins in discovery-phase experiments, only to watch those signals fail to replicate under the...
The advent of single-cell RNA sequencing (scRNA-seq) has fundamentally redefined transcriptomic profiling by resolving transcriptional states at single cell resolution. Unlike bulk RNA-seq, which obscures cell-to-cell variability through population averaging,...
Gynecological cancers, including ovarian, cervical, uterine, and endometrial cancers, remain some of the most complex malignancies to study. While survival has improved in many cancers, uterine corpus cancer is trending...
Gynecological cancers, including ovarian, cervical, uterine, and endometrial cancers, remain some of the most complex malignancies to study. While survival has improved in many cancers, uterine corpus cancer is trending...